Karla Kopp
Novo Nordisk (Denmark)(DK)Mayo Clinic in Arizona(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, RNA modifications and cancer, Cancer-related Molecular Pathways, Ferroptosis and cancer prognosis, Genetic factors in colorectal cancer
Most-Cited Works
- → Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods(2019)93 cited
- → Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers(2015)47 cited
- → Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma(2025)5 cited
- → Cytotechnologists as coinvestigators in anatomical pathology research(2018)4 cited
- → Abstract P5-01-01: Blood-based cancer detection in plasma cell-free DNA (cfDNA): Evaluating clinical and pathologic tumor characteristics in participants with breast cancer(2020)2 cited
- → MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform(2025)2 cited
- → Issue Information(2018)